Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03893500 · ClinicalTrials.gov registry record · NA

Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test

A NA study of Pulmonary Arterial Hypertension, sponsored by Stanford University.

Active
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT03893500 is a NA study of Pulmonary Arterial Hypertension that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 63 participants, below the 461-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03893500, a NA study of Pulmonary Arterial Hypertension, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

* Evaluate for accuracy and reproducibility of data collected via the participant-operated Walk.Talk.Track. (WTT) app combined with Apple Watch during in-clinic, technician proctored 6MWT's. * Determine whether the WTT app on the Apple Watch can accurately collect information on distance traveled and heart rate (HR) during in-clinic 6MWT run by American Thoracic Society (ATS) guidelines * Determine whether participants can operate the WTT app and Apple Watch effectively to gather accurate data in a monitored and home-based setting * Prospectively monitor for changes in WTT app recorded 6MWT results following initiation of therapy in a treatment naïve cohort of PAH participants * Evaluate whether changes from baseline in 6 minute walk distance (6MWD) and heart rate recovery at one minute (HRR1) as well as other variables that have been associated with disease severity in PAH and left-sided heart disease (resting HR, heart rate variability \[HRV\], chronotropic index \[CI\]) can be identified before the 12-week follow up when comparing the treatment arm and the control arm * Evaluate whether changes from baseline in the HRR1, resting HR, HRV and/or CI are more evident in treatment responders when compared to treatment non-responders.

Interventions

  • DEVICE Home-based 6 minute walk test

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2020-07-01
Est. Completion 2025-06-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03893500

The ClinicalTrials.gov registry entry for NCT03893500 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 461-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Home-based 6 minute walk test is the first listed.

NCT03893500 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03893500 about?

NCT03893500 is a clinical study titled "Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test". * Evaluate for accuracy and reproducibility of data collected via the participant-operated Walk.Talk.Track. (WTT) app combined with Apple Watch during in-clinic, technician proctored 6MWT's. * Determine whether the WTT app on the Apple Watch can accurately collect information on distance traveled...

What is the current status of trial NCT03893500?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2020-07-01. Estimated completion is 2025-06-30.

What conditions does trial NCT03893500 study?

This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.

What interventions are being tested in trial NCT03893500?

The interventions under investigation include: Home-based 6 minute walk test (DEVICE).

Who is sponsoring clinical trial NCT03893500?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03893500 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Arterial Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.